BPC-157 250 to 500 mcg subcutaneously, either near the injury or in the abdomen, once daily
In animal behavioral tests, n 10
Anemia, fatigue Poor memory, memory loss, confusion, delirium and paranoia Shortness of Breath (also may indicate low iron) Feeling unstable, dizzy, or off-balance Swollen tongue, reduced taste buds Hyper-pigmentation of the skin, yellowing of the skin Neurological disorders (numbness and tingling in the hands and feet, migraines, neuritis, sciatica, etc.) Mental health symptoms (anxiety, depression) Gastrointestinal symptoms (constipation, diarrhea, dyspepsia) Musculoskeletal (back pain, bursitis, muscle cramps, osteoporosis)
This biological infrastructure makes the gastrointestinal tract a natural target for peptide-based research and two compounds in particular have emerged with substantial published evidence: BPC-157 and KPV